Liraglutide

Drug ingredientActive Shortage

CAS 204656-20-2

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Molecular structure of 204656-20-2
US productionNot reported
Import value, 2024$16.4B
Top sourceIreland 94%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293719 · basket

These shares come from HS customs code 293719, which covers 53 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries
IE 94%IrelandAR 4%ArgentinaCN 1%ChinaDK 1%Denmark
37 FDA-registered drug labelers
A-S Medication Solutions
Aurobindo Pharma Limited
Bachem Americas, Inc.
Biocon Limited
Biocon Pharma Inc.
Chengdu Shengnuo Biopharm Co. Ltd.
Cipla USA Inc.
DARMERICA, LLC
Dr. Reddy's Laboratories Limited
ETERNAL WEALTH(CHINA)LIMITED
FRESENIUS KABI IPSUM SRL
Fujian Genohope Biotech Ltd.
Hikma Pharmaceuticals USA Inc.
Hubei JXBio Pharmaceutical Co., Ltd
Hybio Pharmaceutical Co., Ltd.
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
Lupin Pharmaceuticals, Inc.
Meitheal Pharmaceuticals Inc.
MSN Life Sciences Private Limited
Nanjing Chengong Pharmaceutical Co., Ltd.
Nanjing Hanxin Pharmaceutical Technology Co., Ltd.
Nanjing Xingyin Pharmaceutical Group Co.,Ltd
NOMIDA LLC
NorthStar Rx LLC
Novo Nordisk
Novo Nordisk A/S
Orbicular Pharmaceutical Technologies Private Limited
Polypeptide Laboratories Inc
Qingdao Biopeptek Co., Ltd.
ScinoPharm Taiwan Ltd.
Shanghai Ambiopharm, Inc
Sinopep-Allsino Biopharmaceutical Co., Ltd.
SUN PHARMACEUTICAL INDUSTRIES, INC.
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals, Inc.
Tonghua Dongbao Pharmaceutical Co., Ltd
Zhejiang Peptites Biotech Co., Ltd.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 4 drug and cosmetic product listings (FDA).

  • •Liraglutide
  • •Xultophy 100/3.6
  • •Victoza
  • •Saxenda
FDA Shortage Status
Active Shortage
Shortage History
  • Current shortage

    Liraglutide Injection

    Shortage listed since July 18, 2023

    Manufacturer reports: 1 limited, 1 available

See all current drug shortages

Chemical Identity

CAS204656-20-2
PubChem CID16134956
DTXSIDDTXSID60174433
FormulaC172H265N43O51
Mol. Weight3751 g/mol
SMILESCCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N)C(=O)O

Data Sources

Brief citations

Liraglutide (CAS 204656-20-2) https://chemicalindependence.com/chemical/204656-20-2/ PubChem: 16134956. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/16134956 FDA National Drug Code directory: CAS 204656-20-2. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 204656-20-2. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293719 for CAS 204656-20-2. Reporting year: 2024. https://usatrade.census.gov/